Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 4 of 4

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Anti-inflammatory effect of YP-P10: upregulation of CD25, FoxP3 and TGFβ/IL-10 co-expression in Behçet’s patients’ blood-derived CD4 + T cells and downregulation of il-17f and ifn g genes by Th17 cells

Virginia L Calder; Mali Eskandarpour; Xin Zuo; Larry C Park; Laxmikant Gharat

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5049.

ARVO Annual Meeting Abstract June 2023

Novel YP-P10 Peptide reduces corneal damage in a mouse dry eye model compared with Lifitegrast, Cyclosporine, Diquafosol sodium and Hyaluronic acid.

Laxmikant Gharat; Larry Park; Kyungho Park; Hyun Woo Park; Gary D Novack

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):699.

ARVO Annual Meeting Abstract June 2023

YP-P10 Peptide selectively decreased Th2 and Th17 cells in an in vitro model of human blood-derived effector CD4 + T-cell subsets.

Virginia L Calder; Malihe Eskandarpour; Larry Park; Laxmikant Gharat

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3919.

ARVO Annual Meeting Abstract June 2022

Evaluation of novel YP-P10 Peptide in animal models of inflammatory dry eye disease

Larry Chong Park; Laxmikant Gharat; Kyungho Park; Jahan Alam; Zhiyuan Yu; Yelin Hu; Cintia S De Paiva; Gary D Novack; Stephen C Pflugfelder

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1984 – A0314.

Advertisement